Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-10-30

FDA Approved: TELMISARTAN — Original Application (Ascend Laboratories, LLC)

View source ↗

Summary

FDA approved Ascend Laboratories' original ANDA for Telmisartan, enabling a generic version of the antihypertensive drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Telmisartan (Telmisartan)

Snippet

ORIG AP for TELMISARTAN (TELMISARTAN)